(Q36266689)

English

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

cerebrospinal fluid

0 references

object named as

Ronald J Ellis

5

0 references

12

object named as

Igor Grant

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

3

object named as

Scott Letendre

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

11

object named as

Susan Morgello

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

13

object named as

CHARTER Group

1 reference

Europe PubMed Central

13 August 2017

PMC publication ID

Benjamin B Gelman

8

object named as

Benjamin B Gelman

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Justin C McArthur

9

object named as

Justin C McArthur

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

2

object named as

Brookie M Best

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David J Croteau

1

object named as

David Croteau

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

John Allen McCutchan

10

object named as

John Allen McCutchan

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7

object named as

Ann C Collier

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Steven S Rossi

4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

David B Clifford

6

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 April 2012

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

26

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

890-893

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

30 September 2017

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

30 September 2017

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

30 September 2017

Effects of ritonavir on indinavir pharmacokinetics in cerebrospinal fluid and plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

30 September 2017

Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

30 September 2017

Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

22 September 2018

Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

22 September 2018

Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

22 September 2018

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454507

22 September 2018

CSF and serum orosomucoid (alpha-1-acid glycoprotein) in patients with multiple sclerosis: a comparison among particular subgroups of MS patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22313954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical assessment of the distribution of maraviroc to potential human immunodeficiency virus (HIV) sanctuary sites in the central nervous system (CNS) and gut-associated lymphoid tissue (GALT)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22313954

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1097/QAD.0B013E328351F627

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36266689&oldid=1979909577"